CO4480018A1 - Una composicion de un acido policarboxilico reticulado bioa- dhesivo con un agente contra enfermedades transmitidas se- xualmente y metodo para suministrar esta formulacion - Google Patents

Una composicion de un acido policarboxilico reticulado bioa- dhesivo con un agente contra enfermedades transmitidas se- xualmente y metodo para suministrar esta formulacion

Info

Publication number
CO4480018A1
CO4480018A1 CO95046725A CO95046725A CO4480018A1 CO 4480018 A1 CO4480018 A1 CO 4480018A1 CO 95046725 A CO95046725 A CO 95046725A CO 95046725 A CO95046725 A CO 95046725A CO 4480018 A1 CO4480018 A1 CO 4480018A1
Authority
CO
Colombia
Prior art keywords
composition
polycarboxylic acid
stds
formulation
dhesive
Prior art date
Application number
CO95046725A
Other languages
English (en)
Inventor
William J Bologna
Howard L Levine
Original Assignee
Columbia Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Lab Inc filed Critical Columbia Lab Inc
Publication of CO4480018A1 publication Critical patent/CO4480018A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/14—Topical contraceptives and spermacides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1. METODO PARA SUMINISTRAR UN AGENTE ANTI-STD A UN SUJETO QUE COMPRENDE INSERTAR UNA FORMULACION DE POLIMERO DE ACID0 POLICARBOXILICO RETICULADO BIO-ADHESIVO CON EL AGENTE ANTI-STD EN UNA CAVIDAD DEL CUERPO EN UNA CANTIDAD SUFICIENTE PARA MOSTRAR ACTIVIDAD ANTI-STD SIN CAUSACION SIGNIFICATIVA DE IRRITACION A LOS TEJIDOS EPITELIALES LOCALES. 13. UNA COMPOSICION DE SUMINISTRO DE DROGA QUE CONTIENE UNA FORMULACION DE POLIMERO DE ACIDO PO- LICARBOXILICO RETICULADO BIO-ADHESIVO CON UNA CAN- TIDAD DE UN AGENTE ANTI-STD SUFICIENTE, LUEGO DEL SUMINISTRO A UNA CAVIDAD DEL CUERPO, PARA DEMOS- TRAR ACTIVIDAD ANTI-STD SIN CAUSACION SIGNIFICATI- VA DE IRRITACION A LOS TEJIDOS EPITELIALES LOCA- LES. FIGURA 1
CO95046725A 1994-10-07 1995-10-06 Una composicion de un acido policarboxilico reticulado bioa- dhesivo con un agente contra enfermedades transmitidas se- xualmente y metodo para suministrar esta formulacion CO4480018A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/319,495 US5667492A (en) 1994-10-07 1994-10-07 Use and composition of an anti-sexually transmitted diseases formulation

Publications (1)

Publication Number Publication Date
CO4480018A1 true CO4480018A1 (es) 1997-07-09

Family

ID=23242477

Family Applications (1)

Application Number Title Priority Date Filing Date
CO95046725A CO4480018A1 (es) 1994-10-07 1995-10-06 Una composicion de un acido policarboxilico reticulado bioa- dhesivo con un agente contra enfermedades transmitidas se- xualmente y metodo para suministrar esta formulacion

Country Status (24)

Country Link
US (2) US5667492A (es)
EP (1) EP0784466B1 (es)
JP (1) JPH10507178A (es)
KR (1) KR970705976A (es)
AT (1) ATE213623T1 (es)
AU (1) AU704836B2 (es)
BR (1) BR9509280A (es)
CA (1) CA2201872A1 (es)
CO (1) CO4480018A1 (es)
DE (1) DE69525634T2 (es)
DK (1) DK0784466T3 (es)
ES (1) ES2173203T3 (es)
FI (1) FI971440A0 (es)
HU (1) HUT77527A (es)
IL (1) IL115495A0 (es)
MA (1) MA23687A1 (es)
MX (1) MX9504245A (es)
NO (1) NO971491L (es)
NZ (1) NZ295947A (es)
PE (1) PE46996A1 (es)
PT (1) PT784466E (es)
RU (1) RU2157184C2 (es)
WO (1) WO1996010989A1 (es)
ZA (1) ZA958434B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596777B1 (en) 1997-05-29 2003-07-22 Mcneil-Ppc, Inc. Moisture containing compositions that are spreadable onto and adherable to biomembranes
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US5942243A (en) * 1996-11-12 1999-08-24 Polytherapeutics, Inc. Mucoadhesive compositions for administration of biologically active agents to animal tissue
WO1998051273A1 (en) * 1997-05-12 1998-11-19 Sage Pharmaceuticals, Inc. Topical spray for burn treatment and anti-infection
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
EP1356806A1 (en) * 1997-09-12 2003-10-29 Columbia Laboratories (Bermuda) Limited A pharmaceutical composition for treating dysmenorrhea and premature labor
US20040234606A1 (en) * 1997-09-12 2004-11-25 Levine Howard L. Localized vaginal delivery without detrimental blood levels
CA2335055A1 (en) 1998-06-19 1999-12-23 Jack Fellman Medical device having anti-infective and contraceptive properties
WO1999066900A2 (de) * 1998-06-23 1999-12-29 Notax Holding Gesellschaft Mbh Verwendung von nonoxynol-9 als gleitmittel sowie verfahren zu seiner herstellung
US6159491A (en) * 1999-02-12 2000-12-12 Biovector Technologies, Inc. Prolonged release bioadhesive vaginal gel dosage form
US6818672B1 (en) 1999-10-05 2004-11-16 Columbia Laboratories, Inc. Treating endometriosis or infertility, or improving fertility
US6479045B2 (en) 1999-12-22 2002-11-12 Columbia Laboratories, Inc. Vaginal pH buffering for preventing miscarriage and premature labor, by treating or preventing bacterial vaginosis
US6706276B2 (en) 2000-03-07 2004-03-16 Rush-Presbyterian-St. Luke's Medical Center Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa
EP1997478B1 (en) * 2001-02-15 2013-09-04 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US7544348B2 (en) * 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US20060073174A1 (en) * 2001-08-16 2006-04-06 Access Pharmaceuticals, Inc. Adherent and erodible film to treat a moist surface of a body tissue
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
JP2005519868A (ja) * 2001-10-16 2005-07-07 アバニール・ファーマシューティカルズ ｎ−ドコサノールによるウイルス阻害
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US20080182841A1 (en) * 2001-10-29 2008-07-31 Levine Howard L Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US7709026B2 (en) * 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
BRPI0407329A (pt) 2003-02-07 2006-01-10 Janssen Pharmaceutica Nv Derivados de pirimidina para a prevenção de infecção de hiv
ES2237298B1 (es) * 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
ITMI20031640A1 (it) 2003-08-08 2005-02-09 Mipharm S P A Base per gel bioadesivi.
US12011423B2 (en) 2007-11-06 2024-06-18 Foraviset Ltd. S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
JP6352907B2 (ja) 2012-06-13 2018-07-04 イボフェム， インコーポレイテッド 避妊殺菌剤の効果を増強するための組成物および方法
NZ722215A (en) 2013-12-19 2019-02-22 Evofem Inc Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound
WO2016008039A1 (en) * 2014-07-14 2016-01-21 Novicol International Holding Inc. Microbicidal composition comprising an octoxynol and a quinolizidine alkaloid compound or a source thereof
EP3522879A4 (en) 2016-10-04 2020-06-03 Evofem, Inc. METHOD OF TREATING AND PREVENTING BACTERIAL VAGINOSIS

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE604564A (es) * 1960-06-06
US4286593A (en) * 1980-05-05 1981-09-01 Place Virgil A Vaginal contraceptive shield
EP0305551A3 (en) * 1981-10-13 1990-01-10 Exovir, Inc. Pharmaceutical compositions for topical application
WO1985002092A1 (en) * 1983-11-14 1985-05-23 Bio-Mimetics Inc. Bioadhesive compositions and methods of treatment therewith
US4983393A (en) * 1987-07-21 1991-01-08 Maximed Corporation Intra-vaginal device and method for sustained drug release
NO178843C (no) * 1988-07-11 1996-06-19 Sspl Sa Safe Sex Prod Licens Fremgangsmåte for fremstilling av et farmasöytisk preparat for å forhindre seksuelt overförbare sykdommer
US5000749A (en) * 1988-10-13 1991-03-19 Leveen Harry H Iodine contraceptive sponge
EP0431719B1 (en) * 1989-10-31 1994-11-09 Columbia Laboratories, Inc. Vaginal tissue moisturizing composition
HU227563B1 (en) * 1989-10-31 2011-08-29 Columbia Lab Bermuda Ltd Process for production of composition for moisturizing of tissue
DE69012955T2 (de) * 1989-10-31 1995-02-09 Columbia Laboratories, Inc., Miami, Fla. Verfahren zur Feuchthaltung von Gewebe und Mittel dazu.
US5380523A (en) * 1993-08-17 1995-01-10 University Of Kentucky Research Foundation High energy coprecipitate of nonoxynol oligomer, PVP and iodine having contraceptive and potent anti-HIV properties

Also Published As

Publication number Publication date
IL115495A0 (en) 1996-01-19
JPH10507178A (ja) 1998-07-14
MA23687A1 (fr) 1996-07-01
NZ295947A (en) 1999-02-25
AU704836B2 (en) 1999-05-06
RU2157184C2 (ru) 2000-10-10
DK0784466T3 (da) 2002-04-22
FI971440A (fi) 1997-04-07
PE46996A1 (es) 1996-11-23
EP0784466A1 (en) 1997-07-23
FI971440A0 (fi) 1997-04-07
HUT77527A (hu) 1998-05-28
BR9509280A (pt) 1997-11-18
MX9504245A (es) 1997-01-31
ES2173203T3 (es) 2002-10-16
NO971491D0 (no) 1997-04-02
US5667492A (en) 1997-09-16
PT784466E (pt) 2002-06-28
AU3961295A (en) 1996-05-02
WO1996010989A1 (en) 1996-04-18
EP0784466B1 (en) 2002-02-27
CA2201872A1 (en) 1996-04-18
DE69525634T2 (de) 2002-08-29
NO971491L (no) 1997-06-09
DE69525634D1 (de) 2002-04-04
US20010006667A1 (en) 2001-07-05
ZA958434B (en) 1996-05-08
ATE213623T1 (de) 2002-03-15
KR970705976A (ko) 1997-11-03

Similar Documents

Publication Publication Date Title
CO4480018A1 (es) Una composicion de un acido policarboxilico reticulado bioa- dhesivo con un agente contra enfermedades transmitidas se- xualmente y metodo para suministrar esta formulacion
IT1251151B (it) Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati
EP2108359B1 (en) Warming and nonirritating lubricant compositions
AR015524A1 (es) FORMULACIoN ESTABLE DE SOLUCIoN DE OXIPLATINO, SU USO PARA LA MANUFACTURA DE UN MEDICAMENTO, PROCESO PARA SU PREPARACIoN, PRODUCTO FARMACÉUTICO QUE LA CONTIENE Y UN MÉTODO PARA ESTABILIZAR UNA SOLUCIoN DE OXALIPLATINO.
MY121743A (en) Progestin therapy with controlled bleeding
ES2055677T1 (es) Procedimiento de obtencion de una composicion para el tratamiento de la disfuncion erectil.
IL153665A0 (en) Topical pharmaceutical formulations and methods of treatment
GB2362100B (en) Wound gels
US5387611A (en) Use of butylurea, nonoxynol-9 and benzalkonium chloride as anti-bacterial, anti-viral contraceptive agents
ES2105332T3 (es) Polimeros quelantes.
DE69524772D1 (de) Ophthalmologisches abgabesystem
KR940005290A (ko) 생점착성 치료 조성물 및 사용방법
RU97107333A (ru) Композиция лекарственной формы для лечения венерических заболеваний и ее применение
MXPA04003976A (es) Agentes antiarritmicos de administracion vaginal para tratamiento de dolor pelvico e infertilidad.
AR003545A1 (es) Composiciones de limpieza liquida espesa, viscoelastica; metodo para su uso
AR006892A1 (es) Uso de formas del acido hialuronico (ha) para el tratamiento del cancer
CA2429982A1 (en) Copper chelators for treating ocular inflammation
JPH0416445B2 (es)
ES2146683T3 (es) Uso de bifemelano para la fabricacion de un medicamento para el tratamiento de trastornos hipercineticos.